IL13 mutants
IL6RIL6 chimera for the treatment of neurodegenerative diseases
IL8 inhibitors
Immunologic enhancement with intermittent interleukin-2 therapy
Immunologic enhancement with intermittent interleukin-2 therapy
Immunologic enhancement with intermittent interleukin-2 therapy
Immunomodulators
Immunopotentiating protocol for chemotherapy-responsive tumors
Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fl
Immunotherapy agents for treatment of IgE mediated allergies
Induction of tolerance to a foreign antigen IL-2 receptor-bindin
Interleukin-1 muteins useful as vaccine adjuvants
Interleukin-15 antagonist peptide
Interleukin-2 mutants with reduced toxicity
Interleukin-2 mutants with reduced toxicity
Interleukin-2 mutein expressed from mammalian cells
Interleukin-6 receptor agonists
Interleukin-6 splice variant
Interleukin-6 to stimulate erythropoietin production
Interleukin-8 as an antiviral and antitumor agent